Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Pagano L, Valentini CG, De Stefano V, Venditti A, Visani G, Petrucci MT et al. Primary plasma cell leukemia: a retrospective multicenter study of 73 patients. Ann Oncol 2011; 22: 1628–1635.

    Article  CAS  PubMed  Google Scholar 

  2. Musto P, Pagano L, Petrucci MT, Morabito F, Caravita T, Di Raimondo F et al. Primary plasma cell leukemia in the era of new drugs: has something changed? Crit Rev Oncol Hematol 2012; 82: 141–149.

    Article  PubMed  Google Scholar 

  3. Van de Donk NW, Lokhorst HM, Anderson KC, Richardson PG . How I treat plasma cell leukemia. Blood 2012; 120: 2376–2389.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Fernández de Larrea C, Kyle RA, Durie BG, Ludwig H, Usmani S, Vesole DH et al. Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia 2013; 27: 780–791.

    Article  PubMed  Google Scholar 

  5. Drake MB, Iacobelli S, van Biezen A, Morris C, Apperley JF, Niederwieser D et al. Primary plasma cell leukemia and autologous stem cell transplantation. Haematologica 2010; 95: 804–809.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Mahindra A, Kalaycio ME, Vela-Ojeda J, Vesole DH, Zhang MJ, Li P et al. Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research. Leukemia 2012; 26: 1091–1097.

    Article  CAS  PubMed  Google Scholar 

  7. Saccaro S, Fonseca R, Veillon DM, Cotelingam J, Nordberg ML, Bredeson C et al. Primary plasma cell leukemia: report of 17 new cases treated with autologous or allogeneic stem-cell transplantation and review of the literature. Am J Hematol 2005; 78: 288–294.

    Article  PubMed  Google Scholar 

  8. Musto P, Rossini F, Gay F, Pitini V, Guglielmelli T, D’Arena G et al. Efficacy and safety of bortezomib in patients with plasma cell leukemia. Cancer 2007; 109: 2285–2290.

    Article  CAS  PubMed  Google Scholar 

  9. Musto P, Pietrantuono G, Guariglia R, Villani O, Martorelli MC, D'Auria F et al. Salvage therapy with lenalidomide and dexamethasone in relapsed primary plasma cell leukemia. Leuk Res 2008; 32: 1637–1638.

    Article  CAS  PubMed  Google Scholar 

  10. Lebovic D, Zhang L, Alsina M, Nishihori T, Shain KH, Sullivan D et al. Clinical outcomes of patients with plasma cell leukemia in the era of novel therapies and hematopoietic stem cell transplantation strategies: a single-institution experience. Clin Lymphoma Myeloma Leuk 2011; 11: 507–511.

    Article  PubMed  Google Scholar 

  11. Avet-Loiseau H, Roussel M, Campion L, Leleu X, Marit G, Jardel H et al. Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience. Leukemia 2012; 26: 158–159.

    Article  CAS  PubMed  Google Scholar 

  12. Usmani SZ, Nair B, Qu P, Hansen E, Zhang Q, Petty N et al. Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols. Leukemia 2012; 26: 2398–2405.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. D'Arena G, Valentini CG, Pietrantuono G, Guariglia R, Martorelli MC, Mansueto G et al. Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party. Ann Oncol 2012; 23: 1499–1502.

    Article  CAS  PubMed  Google Scholar 

  14. Lionetti M, Musto P, Di Martino MT, Fabris S, Agnelli L, Todoerti K et al. Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia. Clin Cancer Res 2013; 19: 3130–3142.

    Article  CAS  PubMed  Google Scholar 

  15. Todoerti K, Agnelli L, Fabris S, Lionetti M, Tuana G, Mosca L et al. Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome. Clin Cancer Res 2013; 19: 3247–3258.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported in part by research funding from Celgene to PM, on behalf of IRCCS, Centro di Riferimento Oncologico della Basilicata, Rionero in Vulture, Italy. We wish to thank Sante Cundari, from Celgene, Italy, for his great contribution to the trial.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P Musto.

Ethics declarations

Competing interests

PM received research financial support for this study and honoraria from Celgene. MTP, NC, FDR, FM, MO, AO, SB, MB and AP have received honoraria from Celgene. Other authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Leukemia website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Musto, P., Simeon, V., Martorelli, M. et al. Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia. Leukemia 28, 222–225 (2014). https://doi.org/10.1038/leu.2013.241

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2013.241

This article is cited by

Search

Quick links